Affymetrix (AFFX) Issues Downbeat Revenue View For 3Q
Affymetrix Inc. (NASDAQ:AFFX), which develops systems for genetic analysis, forecast revenue for the third quarter below market expectations saying its gene expression and eBioscience business units were hit by a tightening academic funding environment worldwide. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here